Clinical Trial

A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC

Name: A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC — clinical trial record (NCT06584071)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study to evaluate the preliminary efficacy, safety and pharmacokinetics of PM8002 combined with PM1009 in Patients with first-line Hepatocellular Carcinoma.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-09-02; most recent amendment 2024-12-10.

Trial Details

NCT Number	NCT06584071
Lead Sponsor	Biotheus Inc.
Conditions	HCC, Liver Cancer
Enrollment	140 participants
Start Date	2024-12
Primary Completion	2026-10 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2024-12-16